
Everest Medicines Announces New Drug Application Approval Of VELSIPITY® For Adults With Moderately To Severely Active ...
(MENAFN- EQS Group) Shanghai, China – April 30, 2025 – Everest Medicines (HKEX 1952,“Everest”, or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative …